A Phase 1 Study of the Safety and Tolerability of CTX-10726
Compass Therapeutics
Compass Therapeutics
GlaxoSmithKline
Hospital Universitari de Bellvitge
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Rutgers, The State University of New Jersey
Kaiser Permanente
Ellele Health
Mayo Clinic
University Hospital, Strasbourg, France
Cogent Biosciences, Inc.
Asan Medical Center
Peking University People's Hospital
European Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
Taipei Veterans General Hospital, Taiwan
European Institute of Oncology
Natera, Inc.
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
Second Life Therapeutics
Peking Union Medical College Hospital